{"DataElement":{"publicId":"2181388","version":"1","preferredName":"Myeloma Progression Site","preferredDefinition":"the anatomic location or a test result indicating that multiple myeloma disease has spread or increased in severity.","longName":"MYE_PROG_SITE","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2181353","version":"1","preferredName":"Myeloma Progression","preferredDefinition":"information related to myeloma progression.","longName":"MYE_PROG","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2177047","version":"1","preferredName":"Myeloma","preferredDefinition":"A bone marrow-based plasma cell neoplasm characterized by a serum monoclonal protein and skeletal destruction with osteolytic lesions, pathological fractures, bone pain, hypercalcemia, and anemia.  Clinical variants include non-secretory myeloma, smoldering myeloma, indolent myeloma, and plasma cell leukemia. (WHO, 2001) -- 2003","longName":"Myeloma","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Multiple Myeloma","conceptCode":"C3242","definition":"A bone marrow-based plasma cell neoplasm characterized by a serum monoclonal protein and skeletal destruction with osteolytic lesions, pathological fractures, bone pain, hypercalcemia, and anemia.  Clinical variants include non-secretory myeloma, smoldering myeloma, indolent myeloma, and plasma cell leukemia. (WHO, 2001)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"ACAAECCE-7AA0-657B-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2177380","version":"1","preferredName":"Progression","preferredDefinition":"Progression; advancement in extent or severity.","longName":"Progression","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Progression","conceptCode":"C25331","definition":"Progression; advancement in extent or severity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE29A78C-5267-3A05-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D40661A4-212D-3596-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-02-23","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-02-23","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2181387","version":"1","preferredName":"Myeloma Progression Site","preferredDefinition":"information related to the site of progression of myeloma.","longName":"MYELOMA_PROG_SITE","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"65","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"blood (SPEP, immunofixation, or quantitative immunoglobulins)","valueDescription":"blood (SPEP, immunofixation, or quantitative immunoglobulins)","ValueMeaning":{"publicId":"2568480","version":"1","preferredName":"blood (SPEP, immunofixation, or quantitative immunoglobulins)","longName":"2568480","preferredDefinition":"blood (SPEP, immunofixation, or quantitative immunoglobulins)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D88D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-02-23","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-02-23","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D40646F7-45A0-3598-E034-0003BA12F5E7","beginDate":"2004-02-23","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-02-23","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"blood (SPEP, immunofixation, or quantitative IgM)","valueDescription":"blood (SPEP, immunofixation, or quantitative IgM)","ValueMeaning":{"publicId":"2568481","version":"1","preferredName":"blood (SPEP, immunofixation, or quantitative IgM)","longName":"2568481","preferredDefinition":"blood (SPEP, immunofixation, or quantitative IgM)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D88E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-02-23","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-02-23","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D40646F7-45A4-3598-E034-0003BA12F5E7","beginDate":"2004-02-23","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-02-23","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"urine (UPEP or immunofixation)","valueDescription":"urine (UPEP or immunofixation)","ValueMeaning":{"publicId":"2568482","version":"1","preferredName":"urine (UPEP or immunofixation)","longName":"2568482","preferredDefinition":"urine (UPEP or immunofixation)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D88F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-02-23","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-02-23","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D40646F7-45A8-3598-E034-0003BA12F5E7","beginDate":"2004-02-23","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-02-23","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"bone marrow","valueDescription":"Bone Marrow","ValueMeaning":{"publicId":"2581613","version":"1","preferredName":"Bone Marrow","longName":"2581613","preferredDefinition":"The tissue occupying the spaces of bone. It consists of blood vessel sinuses and a network of hematopoietic cells which give rise to the red cells, white cells, and megakaryocytes. ","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bone Marrow","conceptCode":"C12431","definition":"The tissue occupying the spaces of bone. It consists of blood vessel sinuses and a network of hematopoietic cells which give rise to the red cells, white cells, and megakaryocytes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0BDA-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-18","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-18","modifiedBy":"ZHWENDY","dateModified":"2022-05-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D40646F7-45AB-3598-E034-0003BA12F5E7","beginDate":"2003-02-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-02-23","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"new or larger bone lesions","valueDescription":"new or larger bone lesions","ValueMeaning":{"publicId":"2568483","version":"1","preferredName":"new or larger bone lesions","longName":"2568483","preferredDefinition":"new or larger bone lesions","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D890-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-02-23","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-02-23","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D40646F7-45AE-3598-E034-0003BA12F5E7","beginDate":"2004-02-23","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-02-23","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"serum calcium","valueDescription":"serum calcium","ValueMeaning":{"publicId":"2568484","version":"1","preferredName":"serum calcium","longName":"2568484","preferredDefinition":"serum calcium","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D891-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-02-23","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-02-23","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4095E74-96E6-5225-E034-0003BA12F5E7","beginDate":"2004-02-23","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-02-23","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"plasmacytoma","valueDescription":"plasmacytoma","ValueMeaning":{"publicId":"2568485","version":"1","preferredName":"plasmacytoma","longName":"2568485","preferredDefinition":"plasmacytoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D892-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-02-23","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-02-23","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4095E74-96EA-5225-E034-0003BA12F5E7","beginDate":"2004-02-23","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-02-23","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"lymph nodes","valueDescription":"Lymph Nodes","ValueMeaning":{"publicId":"2570420","version":"1","preferredName":"Lymph Nodes","longName":"2570420","preferredDefinition":"A bean-shaped organ surrounded by a connective tissue capsule. It is part of the lymphatic system and is found throughout the body. It is composed predominantly of lymphocytes and its main function is immune protection.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lymph Node","conceptCode":"C12745","definition":"A bean-shaped organ surrounded by a connective tissue capsule. It is part of the lymphatic system and is found throughout the body. It is composed predominantly of lymphocytes and its main function is immune protection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E021-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-07-15","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"KUMMEROA","dateModified":"2022-06-10","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 01/30/2015.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4095E74-96EE-5225-E034-0003BA12F5E7","beginDate":"2004-02-23","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-02-23","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"peripheral blood","valueDescription":"PERIPHERAL BLOOD","ValueMeaning":{"publicId":"2559785","version":"1","preferredName":"PERIPHERAL BLOOD","longName":"2559785v1.00","preferredDefinition":"Blood drawn from a limb.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Peripheral Blood","conceptCode":"C173496","definition":"Blood drawn from a limb.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B696-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"KUMMEROA","dateModified":"2023-09-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4095E74-96F1-5225-E034-0003BA12F5E7","beginDate":"2002-08-01","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-02-23","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"liver","valueDescription":"Liver","ValueMeaning":{"publicId":"2567243","version":"1","preferredName":"Liver","longName":"2567243","preferredDefinition":"A large organ located in the upper abdomen. The liver cleanses the blood and aids in digestion by secreting bile.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Liver","conceptCode":"C12392","definition":"A triangular-shaped organ located under the diaphragm in the right hypochondrium. It is the largest internal organ of the body, weighting up to 2 kg. Metabolism and bile secretion are its main functions. It is composed of cells which have the ability to regenerate.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D3B8-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-14","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-14","modifiedBy":"KUMMEROA","dateModified":"2023-03-07","changeDescription":null,"administrativeNotes":"2023.3.7 Alt VM added per ticket request CADSR0002119. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4095E74-96F4-5225-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-02-23","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"spleen","valueDescription":"Spleen","ValueMeaning":{"publicId":"2567549","version":"1","preferredName":"Spleen","longName":"2567549","preferredDefinition":"An organ that produces lymphocytes, filters the blood, stores blood cells, and destroys those that are aging. It is located on the left side of the abdomen near the stomach. (OCC)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Spleen","conceptCode":"C12432","definition":"An organ that is part of the hematopoietic and immune systems. It is composed of the white pulp and the red pulp and is surrounded by a capsule. It is located in the left hypochondriac region. Its functions include lymphocyte production, blood cell storage, and blood cell destruction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D4EA-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-12-19","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D405BB95-47FB-3D87-E034-0003BA12F5E7","beginDate":"2004-01-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-02-23","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"2575365","version":"1","preferredName":"Unknown","longName":"2575365","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F372-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-15","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"MMADDINENI","dateModified":"2024-01-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D405BB95-47FE-3D87-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-02-23","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"other","valueDescription":"Other","ValueMeaning":{"publicId":"2559653","version":"1","preferredName":"Other","longName":"2559653","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B612-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"GDEEN","dateModified":"2023-12-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D405BB95-4800-3D87-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-02-23","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Creatinine","valueDescription":"Creatinine","ValueMeaning":{"publicId":"3260983","version":"1","preferredName":"Creatinine","longName":"3260983","preferredDefinition":"The breakdown product of creatine, a constituent of muscle tissue, that is excreted by the kidney and whose serum level is used to evaluate kidney function.(NCI)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Creatinine","conceptCode":"C399","definition":"The breakdown product of creatine, a constituent of muscle tissue, that is excreted by the kidney and whose serum level is used to evaluate kidney function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA2735D0-7400-77AD-E040-BB89AD4302FC","latestVersionIndicator":"Yes","beginDate":"2011-08-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-08-10","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E8E33AD5-9F47-827D-E040-BB89AD436CBE","beginDate":"2013-10-16","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2013-10-16","modifiedBy":"ONEDATA","dateModified":"2013-10-16","deletedIndicator":"No"},{"value":"Anemia","valueDescription":"Anemia","ValueMeaning":{"publicId":"2568585","version":"1","preferredName":"Anemia","longName":"2568585","preferredDefinition":"A reduction in the number of red blood cells per cu mm, the amount of hemoglobin in 100 ml of blood, and the volume of packed red blood cells per 100 ml of blood. Clinically, anemia represents a reduction in the oxygen-transporting capacity of a designated volume of blood, resulting from an imbalance between blood loss (through hemorrhage or hemolysis) and blood production. Signs and symptoms of anemia may include pallor of the skin and mucous membranes, shortness of breath, palpitations of the heart, soft systolic murmurs, lethargy, and fatigability. --2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anemia","conceptCode":"C2869","definition":"A reduction in the number of red blood cells, the amount of hemoglobin, and/or the volume of packed red blood cells. Clinically, anemia represents a reduction in the oxygen-transporting capacity of a designated volume of blood, resulting from an imbalance between blood loss (through hemorrhage or hemolysis) and blood production. Signs and symptoms of anemia may include pallor of the skin and mucous membranes, shortness of breath, palpitations of the heart, soft systolic murmurs, lethargy, and fatigability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D8F6-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-02-25","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-02-25","modifiedBy":"CURTIST","dateModified":"2011-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E8E33AD5-9F52-827D-E040-BB89AD436CBE","beginDate":"2013-10-16","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2013-10-16","modifiedBy":"ONEDATA","dateModified":"2013-10-16","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2519596","version":"1","preferredName":"Anatomic Site","preferredDefinition":"Named locations of, or within, the body.","longName":"C13717","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anatomic Site","conceptCode":"C13717","definition":"Named locations of or within the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"1D590830-EB8D-14A8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-09-13","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-09-13","modifiedBy":"ONEDATA","dateModified":"2006-09-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D408A2ED-D25E-5418-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-02-23","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-02-23","modifiedBy":"ZIEGLERK","dateModified":"2013-10-16","changeDescription":"Reassignment of Representation term concept from C37901 (site) to C13717 (anatomic site) as part of structured caDSR harmonization activity 10/10/2006.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811950","version":"1","longName":"Multiple Myeloma","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811955","version":"1","longName":"Follow-up","context":"CTEP"}]},{"publicId":"2008594","version":"2.31","longName":"Trial Type Usages (CDE Disease Committees)","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811906","version":"1","longName":"Waldenstrom Macrogl","context":"CTEP"},{"publicId":"2811905","version":"1","longName":"Primary Amyloidosis","context":"CTEP"},{"publicId":"2811904","version":"1","longName":"Multiple Myeloma","context":"CTEP"}]}],"AlternateNames":[{"name":"MYE_PROG_SITE","type":"USED_BY","context":"Alliance"}],"ReferenceDocuments":[{"name":"CRF Text","type":"Preferred Question Text","description":"Sites of Progression","url":null,"context":"CTEP"},{"name":"-COMMENT","type":"COMMENT","description":"Add instruction: mark all that apply","url":null,"context":"CTEP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D4079D28-0045-4D08-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-02-23","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-02-23","modifiedBy":"FORMBUILDER","dateModified":"2014-07-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}